home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Advances in Transgenic Technology Congress 2017

 
  November 24, 2016  
     
 
Oxford Global, The Joseph B. Martin Conference Center at Harvard Medical School, Boston, USA
10 - 11 May 2017



Oxford Global Conferences are proud to present our unmissable Advances in Transgenic Technology Congress, taking place on the 10th and 11th of May 2017 in Boston, US. The conference programme consists of world-class keynote addresses, bringing together over 200 senior level attendees. Due to an increased sophistication in new technology becoming more widely available to researchers such as CRISPR, the transgenic technology market has grown significantly.
 
On Day One of the conference, our esteemed speakers Thom Saunders, Director of the Transgenic Animal Model Core, University of Michigan and Lev Fedorov, Director of OHSU Transgenic Mouse Models Shared Resource, Oregon Health & Science University will discuss state-of-the-art technologies for transgenic genome editing including CRISPR-Cas genome engineering and genotyping strategies.
 
Day Two of the congress presentations will focus on genetics, epigenetics and stem cell manipulation including pluripotent stem cell-based disease models. Speakers include Wojtek Auerbach, Senior Director, Regeneron and John McLaughlin, Director of the Transgenic and Embryonic Stem Cell Core Shared Resource, Ohio State University. Presentations will also cover novel implantation and injection systems.
 
Co-located with our Genome Editing USA Congress, for the latest conference updates follow us on Twitter @GEEN_Conf and join the event conversation on #GEENUS17
 
 
Organized by: Oxford Global
Invited Speakers:

Confirmed Speakers Include:

  • Nicholas Gale, Senior Director Therapeutic Target Discovery, Regeneron
  • Wojtek Auerbach, Senior Director Embryonic Stem Cell Technologies, Regeneron
  • Lev Fedorov, Director of OHSU Transgenic Mouse Models Shared Resource, Knight Cancer Institute at Oregon Health & Science University
  • John McLaughlin, Director of the Transgenic and Embryonic Stem Cell Core Shared Resource and Associate Professor, Ohio State University
  • Sang Yong Kim, Director of Rodent Genetic Engineering Laboratory and Research Associate Professor, NYU School of Medicine
  • William Velander, Professor, University of Nebraska

 

 

 
Deadline for Abstracts: N/A
 
Registration: For more information on how to register for the conference contact Danielle Dalby at d.dalby@oxfordglobal.co.uk or call +44 (0) 1865 248455
E-mail: d.dalby@oxfordglobal.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.